Maximilian Steinhardt

14PUBLICATIONS
106CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursReceptors and membrane biologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 18, 2026
Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases.

|Jun 08, 2026
Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis.

|Apr 17, 2026
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure.

|Feb 13, 2026
Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy.

Jan H Frenking, Christine Riedhammer, Thomas Hielscher

|Feb 04, 2026
Single-molecule localization microscopy reveals the molecular organization of endogenous membrane receptors.

Patrick Eiring, Maximilian J Steinhardt, Nele Bauer

|Nov 01, 2025
Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement.

Maximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt

Pageof 3

Frequent Collaborators

9 joint publications

Martin Kortüm

7 joint publications

Hermann Einsele

5 joint publications

Leo Rasche

3 joint publications

Marie Harzer